Dynorphin A(1-8): stability and implications for in vitro opioid activity

Canadian Journal of Physiology and Pharmacology

Volumn 76, Issue 3, 1998, Pages 325-333

  Bell, K M ^a,b,c   Traynor, J R ^a,b  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Dynorphin A(1 8); Guinea pig ileum; Mouse vas deferens; Opioid receptors; Peptide metabolism

Indexed keywords

DELTA OPIATE RECEPTOR; DYNORPHIN[1-8]; ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; KELATORPHAN; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE RECEPTOR; PEPTIDASE; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG STABILITY; GLIOMA CELL; GUINEA PIG; ILEUM; IN VITRO STUDY; MALE; MOUSE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; RAT; VAS DEFERENS;

EID: 0031848697     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y98-020     Document Type: Article

References (43)

1. Abe, J., Okamura, H., Kitamura, T., Ibata, Y., Minamino, N., Matsuo, H., and Paull, W.K. 1988. Immunocytochemical demonstration of dynorphin-like immunoreactive elements in the human hypothalamus. J. Comp. Neurol. 276: 508-513.
2. Aranlakshana, O., and Schild, H.O. 1959. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14: 48-58.
3. Barelli, H., Vincent, J.P., and Checler, F. 1993. Rat kidney endopeptidase 24.16. Purification, physico-chemical characteristics and differential specificity towards opiates, tachykinins and neurotensin-related peptides. Eur. J. Biochem. 211: 79-90.
4. Berman, Y., Devi, L., and Carr, K.D. 1994. Effects of chronic food restriction on prodynorphin-derived peptides in rat brain regions. Brain Res. 664: 49-53.
5. Carlton, S.M., and Hayes, E.S. 1989. Dynorphin A(1-8) immunoreactive cell bodies, dendrites and terminals are postsynaptic to calcitonin gene-related peptide primary afferent terminals in the monkey dorsal horn. Brain Res. 504: 124-128.
6. Chavkin, C., and Goldstein, A. 1981. Specific receptor for the opioid peptide dynorphin: structure-activity relationships. Proc. Natl. Acad. Sci. U.S.A. 78: 6543-6547.
7. Corbett, A.D., Paterson, S.J., McKnight, A.T., Magnan, J., and Kosterlitz, H.W. 1982. Dynorphin 1-8 and dynorphin 1-9 are ligands for the kappa-subtype of opiate receptor. Nature (London), 299: 79-81.
8. 5]enkephalin from dynorphin A(1-8) by rat central nervous tissue in vitro. J. Neurochem. 54: 1379-1385.
9. 5]enkephalin. Br. J. Pharmacol. 101: 674-678.
10. Fallon, J.H., and Leslie, F.M. 1986. Distribution of dynorphin and enkephalin peptides in the rat brain. J. Comp. Neurol. 249: 293-336.
11. 3H]dynorphin A (1-9) in suspensions of guinea pig brain membranes. J. Neurochem. 45: 1034-1042.
12. Hayashi, M.A., Gomes, M.D., Reboucas, N.A., Fernandes, B.L., Ferro, E.S., and Camargo, A.C. 1996. Species specificity of thimet oligopeptidase (EC 3.4.24.15). Biol. Chem. Hoppe-Seyler, 377: 283-291.
13. Healy, D.J., and Meador-Woodruff, J.H. 1994. Prodynorphin-derived peptide expression in primate cortex and striatum. Neuropeptides, 27: 277-284.
14. 7 in mice. Eur. J. Pharmacol. 253: 293-296.
15. Kest, B., Orlowski, M., and Bodnar, R.J. 1991. Increases in opioid-mediated swim antinociception following endopeptidase 24.15 inhibition. Physiol. Behav. 50: 843-845.
16. Kest, B., Orlowski, M., and Bodnar, R.J. 1992. Endopeptidase 24.15 inhibition and opioid antinociception. Psychopharmacology (Berl.), 106: 408-416.
17. Kosterlitz, H.W., and Watt, A.J. 1968. Kinetic parameters of narcotic agonists and antagonists with particular reference to N-allylnoroxymorphone (naloxone). Br. J. Pharmacol. 33: 226-270.
18. Le, H.-T., Michelot, R., Dumont, M., Shukla, V.K., Mayer, M., Nguyen, K.P.-P., Ruan, H., and Lemaire, S. 1997. Design of potent dynorphin A-(1-9) analogues devoid of supraspinal motor effects in mice. Can. J. Physiol. Pharmacol. 75: 9-14.
19. Leckman, J.F., Riddle, M.A., Berrettini, W.H., Anderson, G.M., Hardin, M., Chappell, P., Bissette, G., Nemeroff, C.B., Goodman, W.K., and Cohen, D.J. 1988. Elevated CSF dynorphin A [1-8] in Tourette s syndrome. Life Sci. 43: 2015-2023.
20. Lord, J.A., Waterfield, A.A., Hughes, J., and Kosterlitz, H.W. 1977. Endogenous opioid peptides: multiple agonists and receptors. Nature (London), 267: 495-499.
21. McKnight, A.T., Corbett, A.D., and Kosterlitz, H.W. 1983. Increase in potencies of opioid peptides after pcptidase inhibition. Eur. J. Pharmacol. 86: 393-402.
22. Mentlein, R., and Dahms, P. 1994. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes. J. Neurochem. 62: 27-36.
23. Mosberg, H.I., Hurst, R., Hruby, V.J., Gee, K., Yamamura, H.I., Galligan, J.J., and Burks, T.F. 1983. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc. Natl. Acad. Sci. U.S.A. 80: 5871-5874.
24. Munson, P.J., and Rodbard, D. 1980. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239.
25. Nahin, R.L., Hylden, J.L., and Humphrey, E. 1992. Demonstration of dynorphin A 1-8 immunoreactive axons contacting spinal cord projection neurons in a rat model of peripheral inflammation and hyperalgesia. Pain, 51: 135-143.
26. Nakazawa, T., Furuya, Y., Kaneko, T., Yamatsu, K., Yoshino, H., and Tachibana, S. 1990. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice. J. Pharmacol. Exp. Ther. 252: 1247-1254.
27. Nakazawa, T., Furuya, Y., Kaneko, T., and Yamatsu, K. 1991. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice. J. Pharmacol. Exp. Ther. 256: 76-81.
28. Orlowski, M., Michaud, C., and Molineaux, C.J. 1988. Substrate-related potent inhibitors of brain metalloendopeptidase. Biochemistry, 27: 597-602.
29. Ozaki, M., Miyamoto, Y., Kishioka, S., Masud! Y., and Yamamoto, H. 1994. Participation of opioid receptor types on post-tetanic twitch inhibition in isolated guinea-pig ileal longitudinal muscle. Neuropharmacology, 33: 671-679.
30. 5-enkephalin-, and dynorphin A (1-8)-like materials in the spinal cord and dorsal root ganglia of adult rats: effects of dorsal rhizotomy and neonatal capsaicin. J. Neurochem. 55: 1122-1130.
31. Portoghese, P.S., Lipowski, A.W., and Takemori, A.E. 1987. Bimorphinans as highly selective, potent κ-opioid receptor antagonists. J. Med. Chem. 30: 238-239.
32. Ramsdell, C.D., and Meador-Woodruff, J.H. 1993. Expression of prodynorphin-derived peptides and mRNA in guinea-pig cortex. Neuropeptides, 25: 131-138.
33. Riley, R.C., Zhao, Z.Q., and Duggan, A.W. 1996. Spinal release of immunoreactive dynorphin A(1-8) with the development of peripheral inflammation in the rat. Brain Res. 710: 131-142.
34. Rocha, L.L., Evans, C.J., and Maidment, N.T. 1997. Amygdala kindling modifies extracellular opioid peptide content in rat hippocampus measured by microdialysis. J. Neurochem. 68: 616-624.
35. Rodd, D., and Hersh, L.B. 1995. Endopeptidase 24.16B. A new variant of endopeptidase 24.16. J. Biol. Chem. 270: 10 056-10 061.
36. Roques, B.P., Fournie-Zaluski, M.C., Soroca, E., Lecomte, J.M., Malfroy, B., Llorens, C., and Schwartz, J.C. 1980. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature (London), 288: 286-288.
37. 8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat. J. Pharmacol. Exp. Ther. 262: 979-986.
38. Schmidhammer, H., Jennewein, H.K., Krassnig, R., Traynor, J.R., Patel, D., Bell, K., Froschauer, G., Mattersberger, K., Jachs-Ewinger, C., Jura, P., Fraser, G.L., and Kalinin, V.N. 1985. Synthesis and biological evaluation of 14-alkoxymorphinans. 11. 3-Hydroxycyprodime and analogues: opioid antagonist profile in comparison to cyprodime. J. Med. Chem. 38: 3071-3077.
39. Smotherman, W.P., Robinson, S.R., Varlinskaya, E.I., Petrov, E.S., Orlowski, M., de Costa, B.R., and Rice, K.C. 1994. Central administration of the endopeptidase 24.15 inhibitor cFP-AAF-pAB suggests dynorphin as the endogenous ligand underlying behavioral effects of milk in the fetal rat. Pharmacol. Biochem. Behav. 47: 715-719.
40. Taquet, H., Javoy-Agid, F., Mauborgne, A., Benoliel, J.J., Agid, Y., Legrand, J.C., Tramu, G., Cesselin, F., and Hamon, M. 1988. Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortex. Neuroscience, 27: 871-883.
41. Traynor, J.R., Corbett, A.D., and Kosterlitz, H.W. 1987. Diprenorphine has agonist activity at opioid kappa-receptors in the myenteric plexus of the guinea-pig ileum. Eur. J. Pharmacol. 137: 85-89.
42. Weber, E., Evans, C.J., and Barchas, J.D. 1982. Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain region. Nature (London), 299: 77-79.
43. Zadina, J.E., Hackler, L., Ge, L.-J., and Kastin, A.J. 1997. A potent and selective endogenous agonist for the μ-opioid receptor. Nature (London), 386: 499-502.